Starting from a molecular pharmacophore, which is a marker of drug action in medicinal molecules, we propose that the heterosynthon, a supramolecular synthon between unlike functional groups, plays an analogous role in the design and discovery of high bioavailability drugs. The heterosynthon could provide a more efficient and economical route to novel drugs.
Keywords: cocrystals; crystal engineering; drug discovery; pharmaceutical development; supramolecular synthons.
© 2022 Wiley-VCH GmbH.